NDC 50580-338
IMODIUM Multi-Symptom Relief
Loperamide Hydrochloride And Dimethicone
IMODIUM Multi-Symptom Relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division. The primary component is Loperamide Hydrochloride; Dimethicone.
| Product ID | 50580-338_5b2da502-a49a-47cd-ad67-9d246bdd916c |
| NDC | 50580-338 |
| Product Type | Human Otc Drug |
| Proprietary Name | IMODIUM Multi-Symptom Relief |
| Generic Name | Loperamide Hydrochloride And Dimethicone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021140 |
| Labeler Name | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
| Substance Name | LOPERAMIDE HYDROCHLORIDE; DIMETHICONE |
| Active Ingredient Strength | 2 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 50580-338-12
2 BLISTER PACK in 1 CARTON (50580-338-12) > 6 TABLET in 1 BLISTER PACK
| Marketing Start Date | 2008-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50580-338-43 [50580033843]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-07-01 |
| Marketing End Date | 2015-04-30 |
NDC 50580-338-24 [50580033824]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-07-01 |
| Marketing End Date | 2015-04-30 |
NDC 50580-338-25 [50580033825]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-07-01 |
| Marketing End Date | 2014-07-23 |
NDC 50580-338-12 [50580033812]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-07-01 |
NDC 50580-338-02 [50580033802]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-07-01 |
| Marketing End Date | 2014-07-23 |
NDC 50580-338-60 [50580033860]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-06-14 |
NDC 50580-338-42 [50580033842]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-07-01 |
NDC 50580-338-18 [50580033818]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-07-01 |
NDC 50580-338-30 [50580033830]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-07-01 |
NDC 50580-338-61 [50580033861]
IMODIUM Multi-Symptom Relief TABLET
| Marketing Category | NDA |
| Application Number | NDA021140 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-06-24 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LOPERAMIDE HYDROCHLORIDE | 2 mg/1 |
OpenFDA Data
| SPL SET ID: | ecb91e47-2b0c-47c8-9256-4623d8bc825e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Trademark Results [IMODIUM]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 IMODIUM 73017758 1005190 Live/Registered |
JANSSEN PHARMACEUTICA N.V. 1974-04-02 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.